GGrantIndex
Sort

53,477 grants matching addiction

Northeast Node of the National Drug Abuse Clinical Trials Network

$748,377
Lisa A Marsch · Dartmouth College · UG1 · FY2016 · DA

Northeast Node of the National Drug Abuse Clinical Trials Network

$748,377
Lisa A Marsch · Dartmouth College · UG1 · FY2017 · DA

The role of cancer stem cells in liver cancer heterogeneity and subtypes

$748,373
Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Genetic Variation in Opioid Induced Respiratory Depression in Mice

$748,295
Jason A Bubier · Jackson Laboratory · R01 · FY2020 · DA

Knock and Talk: Public Health-Public Safety Partnerships for Post-Overdose Outreach and Prevention

$748,286
Alexander Yale Walley · Boston Medical Center · R01 · FY2018 · CE

Knock and Talk: Public Health-Public Safety Partnerships for Post-Overdose Outreach and Prevention

$748,242
Alexander Yale Walley · Boston Medical Center · R01 · FY2019 · CE

Multi-modal profiling of spatially resolved cell types mediating opioid withdrawal

$748,196
Xiaoke Chen · Stanford University · R01 · FY2024 · DA

Substance use disorder treatment centers and facility ownership changes

$747,956
Susan H Busch · Yale University · R01 · FY2024 · DA

Training and Education Core p270-287

$747,953
Thomas Evan Eissenberg · Virginia Commonwealth University · P50 · FY2015 · DA

Overdose Risk Management and Compensation in the Era of Naloxone

$747,873
Alexander S Bennett · New York University · R01 · FY2020 · DA

Validation of a novel cerebellar-striatal satiety circuit in human

$747,784
Laura McGrath Holsen · Brigham And Women'S Hospital · R01 · FY2025 · DK

The Impact of Menthol Flavoring on Switching in Adult Menthol Smokers

$747,745
Nicole L Nollen · University Of Kansas Medical Center · R01 · FY2024 · DA

The National Drug Abuse Treatment Clinical Trials Network

$747,675
Roger D. Weiss · Mclean Hospital · UG1 · FY2016 · DA

Marketing, FDA communication, tobacco perceptions and use in addiction treatment

$747,665
Joseph R Guydish · University Of California, San Francisco · R01 · FY2015 · DA

Clinical Pharmacology of Electronic Cigarettes

$747,662
Neal L Benowitz · University Of California, San Francisco · R01 · FY2019 · DA

Prazosin Treatment for Alcohol Use Disorder with Alcohol Withdrawal Symptoms

$747,658
Rajita Sinha · Yale University · R01 · FY2021 · AA

Long-Term Abstinence Clinical Issues and CNS Disinhibition

$747,583
George Fein · Neurobehavioral Research, Inc. · R01 · FY2009 · AA

Enabling Shared Analysis and Processing of Large Neurophysiology Data

$747,542
William J Schroeder · Kitware, Inc. · R44 · FY2017 · MH

Linkage navigation to enhance initiation and engagement in treatment for opioid use disorder to prevent overdose.

$747,531
Alia Al-Tayyib · Denver Health And Hospital Authority · R01 · FY2018 · CE

Rapid initiation of buprenorphine/naloxone to optimize MAT utilization in Philadelphia

$747,512
David S Metzger · University Of Pennsylvania · R01 · FY2020 · CE

Southern Consortium Node of the Clinical Trials Network

$747,500
Kathleen Theresa Brady · Medical University Of South Carolina · UG1 · FY2018 · DA

Southern Consortium Node of the Clinical Trials Network

$747,500
Kathleen Theresa Brady · Medical University Of South Carolina · UG1 · FY2019 · DA

Southern Consortium Node of the Clinical Trials Network

$747,500
Kathleen Theresa Brady · Medical University Of South Carolina · UG1 · FY2017 · DA

Southern Consortium Node of the Clinical Trials Network

$747,500
Kathleen Theresa Brady · Medical University Of South Carolina · UG1 · FY2016 · DA

Southern Consortium Node of the Clinical Trials Network

$747,500
Kathleen Theresa Brady · Medical University Of South Carolina · UG1 · FY2015 · DA